AAAAAA

   
Results: 1-11 |
Results: 11
Molecular characterisation of aureocin A70, a multipeptide bacteriocin isolated from Staphylococcus aureus
Authors: Netz, DJA Sahl, HG Marcolino, R Nascimento, JD de Oliveira, SS Soares, MB Bastos, MDD
Citation: Dja. Netz et al., Molecular characterisation of aureocin A70, a multipeptide bacteriocin isolated from Staphylococcus aureus, J MOL BIOL, 311(5), 2001, pp. 939-949
GIS-supported investigation of a nosocomial Salmonella outbreak
Authors: Kistemann, T Dangendorf, F Krizek, L Sahl, HG Engelhart, S Exner, M
Citation: T. Kistemann et al., GIS-supported investigation of a nosocomial Salmonella outbreak, INT J HYG E, 203(2), 2000, pp. 117-126
New insights into the mechanism of action of lantibiotics - diverse biological effects by binding to the same molecular target
Authors: Brotz, H Sahl, HG
Citation: H. Brotz et Hg. Sahl, New insights into the mechanism of action of lantibiotics - diverse biological effects by binding to the same molecular target, J ANTIMICRO, 46(1), 2000, pp. 1-6
Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061
Authors: Beukes, M Bierbaum, G Sahl, HG Hastings, JW
Citation: M. Beukes et al., Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061, APPL ENVIR, 66(1), 2000, pp. 23-28
Posttranslationally modified bacteriocins - The lantibiotics
Authors: Guder, A Wiedemann, I Sahl, HG
Citation: A. Guder et al., Posttranslationally modified bacteriocins - The lantibiotics, BIOPOLYMERS, 55(1), 2000, pp. 62-73
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany
Authors: Bierbaum, G Fuchs, K Lenz, W Szekat, C Sahl, HG
Citation: G. Bierbaum et al., Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany, EUR J CL M, 18(10), 1999, pp. 691-696
Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype
Authors: Pag, U Heidrich, C Bierbaum, G Sahl, HG
Citation: U. Pag et al., Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype, APPL ENVIR, 65(2), 1999, pp. 591-598
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic
Authors: Breukink, E Wiedemann, I van Kraaij, C Kuipers, OP Sahl, HG de Kruijff, B
Citation: E. Breukink et al., Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic, SCIENCE, 286(5448), 1999, pp. 2361-2364
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147
Authors: Ryan, MP Jack, RW Josten, M Sahl, HG Jung, G Ross, RP Hill, C
Citation: Mp. Ryan et al., Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147, J BIOL CHEM, 274(53), 1999, pp. 37544-37550
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S-aureus strains and demonstration of an association with the exfoliative toxin B gene
Authors: Navaratna, MADB Sahl, HG Tagg, JR
Citation: Madb. Navaratna et al., Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S-aureus strains and demonstration of an association with the exfoliative toxin B gene, INFEC IMMUN, 67(8), 1999, pp. 4268-4271
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55
Authors: Navaratna, MADB Sahl, HG Tagg, JR
Citation: Madb. Navaratna et al., Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55, APPL ENVIR, 64(12), 1998, pp. 4803-4808
Risultati: 1-11 |